Selected Grants
Epigenetic Programming of T Cells for Enhanced Cellular Immunotherapy
ResearchPostdoctoral Associate · Awarded by National Cancer Institute · 2024 - 2029Epigenetically Enhanced Cell Therapy for Hodgkins Lymphoma
ResearchPostdoctoral Associate · Awarded by UH Harrington Discovery Institute · 2025 - 2027High-Throughput Functional Annotation of Gene Regulatory Elements and Variants Critical to Complex Cellular Phenotypes
ResearchPostdoctoral Associate · Awarded by National Human Genome Research Institute · 2021 - 2026The Duke FUNCTION Center: Pioneering the comprehensive identification of combinatorial noncoding causes of disease
ResearchResearch Associate · Awarded by National Human Genome Research Institute · 2020 - 2025Enhancing Neuronal Reprogramming with Epigenome Editing
ResearchAssociate in Research · Awarded by National Institutes of Health · 2018 - 2021External Relationships
- Sollus Therapeutics, Inc.
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.